While fish collagen peptide is most commonly associated with beauty-from-within nutraceuticals, firms could also increasingly explore its use in sports and active nutrition, according to PB Leiner.
New Zealand biotech firm NewFish is looking to accelerate the development and commercialisation of microalgae-based products through strategic partnerships, with the ambition of creating a “whole new category” in the future.
Swedish probiotic firm Probi is seeking growth in Thailand’s bone and immune health supplement market after its proprietary probiotic strain was added to the country’s positive list.
CJ Food & Nutrition Tech (CJ FNT) is pushing for greater presence in the global nutra market, as it diversifies its portfolio to target consumers with active lifestyles, athletes and esports players.
FrieslandCampina Ingredients said that consumer-led demand for prebiotics and the importance placed on gut health in Australia led the company to file for regulatory approval of its GOS prebiotic ingredient.
Florida-based ingredient firm Valensa International is expanding into South Korea’s joint health supplement market where it sees an opportunity for novel ingredients beyond glucosamine and chondroitin.
South Korea’s Ildong Bioscience has obtained invention patents for three of its probiotic strains for their vitamin production ability, specifically B-vitamins and vitamin C.
A prebiotic being used by pharma giant Bayer has “game-changing potential” due to its ability to negate common side effects, claims supplier NutriLeads, which is reporting growth in key APAC markets.
Sacco System is scaling up its Australian operations having recently launched a new research laboratory to service the growing microbial therapeutics market in APAC.
Australia’s Therapeutic Goods Administration (TGA) has approved for the first time the use of 3-fucosyllactose (3-FL) as a complementary medicine ingredient in listed medicines, such as dietary supplements.
The International Probiotics Association has announced it is expanding its scope to cover a broad range of ‘biotics’ in response to industry growth and market demand.
A Japanese company said it has managed to develop an olive leaf extract that could be incorporated into health supplements to promote stem cell reproduction.
Australia’s milk powder manufacturer ProviCo says that demand for specialised nutrition across different life stages has been growing and it is hoping to cater to such demand by utilising its expertise in milk protein fractionation.
A Shanghai-based nicotinamide mononucleotide (NMN) ingredient firm is hopeful of NMN’s application and business opportunities in the US, despite recent news of the USFDA retracting its status as a New Dietary Ingredient (NDI).
South Korean health supplement firm Yuhan Care, which is seen as a pioneer in the women’s health space domestically, is eyeing overseas expansion in China and South East Asia.
Pesticides contamination and traceability are among the top five concerns that nutraceutical brands have when procuring botanicals, according to Kerala-based Arishina Life Sciences, which has implemented a number of measures to mitigate these challenges.
Here we summed up the 10 most-read nutraceutical ingredient supplier news stories of the year, including Malaysia firm Nexus Wise’s tiger milk mushroom business, Singapore firm MD Pharmaceuticals developing a ‘faster-acting’ vitamin D product with DSM,...
DSM has reduced the production of its vitamin C in its factory at Jiangshan, China, as a string of factors, including economic uncertainties, inflation, and weakened demand has cause existing output at the current pricing to become unsustainable.
Kirin’s first human milk oligosaccharides (HMOs) production plant has commenced operation and the company anticipates that half of the market will be dominated by China in the future.
The taste and nutrition specialist aims to simplify formulation by including nutrient as well as legal requirements that cover 35 countries in an easy-to-use calculator. “This is something we have not experienced yet in the industry.”
DSM has developed a database that could identify the key micronutrient gaps in 11 markets across Asia-Pacific, and in turn, help health supplement brands and manufacturers design products to meet these needs.
Japanese firm Kirin is expanding its presence in South East Asia with its flagship postbiotic ingredient, with collaborations with major dairy companies underway.
FrieslandCampina said its 2’-fucosyllactose trademarked Aequival has been approved by Australia’s and New Zealand’s authorities for use in infant milk formula, and that it is on track in expanding its human milk oligosaccharide (HMO) portfolio.
Gnosis by Lesaffre has developed its first prebiotic ingredient using yeast, with the firm banking on its stability credentials to enable it to be incorporated into a wide range of formats.
Australia’s Pharmako Biotechnologies is launching its first liposomal technology which could be used to increase the bioavailability of nutraceuticals containing nutrients that are hydrophilic and lipophilic in nature.
Gencor Pacific is eyeing new product development opportunities aimed at improving the quality of life in individuals who experience the lingering effects of COVID-19 infection, following new trial findings on one of its trademarked ingredients.
The wellbeing and medical nutrition sectors are booming in China and South East Asia (SEA), says New Zealand dairy giant Fonterra, which has introduced a new portfolio aimed at tackling these needs.
Chinese consumers are leading regional demands for healthier, more nutritious food, such as low- to zero-sugar products and high fibre content, for benefits such as better gut health and quality of life.
Asia is more open than any other market to trying natural products due to its long history of traditional remedies, but scientifically-backed and clinically trialled ingredients are now fast becoming a key consumer demand.
Consumers are willing to make the switch to low-sodium foods in order to reap the health benefits, but with a caveat that these must taste good, according to new data from MSG giant Ajinomoto.
At Vitafoods Europe, functional ingredient expert Taiyo will present brand new concepts which it says will address current consumer trends including healthy ageing, sports nutrition and clean label products.
Health Canada has issued a product license from Health Canada for AP-Bio (also known as KalmCold in Europe), a standardized extract of Andrographis paniculate.
While consumers are clamouring for healthier beverages across APAC, spanning sugar reduction and the added functionality, the regulatory landscape still poses a significant challenge for brands.
Krill oil supplementation is gaining traction amongst Japan’s beauty seekers, claims supplier Aker BioMarine, which recently set up an office in Tokyo.
Global life science business Bioiberica has teamed up with Chinese vitamin and dietary supplements provider ByHealth to expand its joint health product portfolio with the introduction of collagen tablets in China.
House Wellness Foods is eyeing expansion in the Australian and New Zealand markets after its flagship postbiotic has been recognised as a non-novel food by the local authorities.
New Zealand deer milk producer Pāmu is developing a range of nutritional supplements for beauty and general health applications, with products expected to launch in Vietnam this March.
Nagasaki University and Kirin Holdings are embarking on a joint clinical research to assess the effect of lactic acid bacteria on relieving symptoms in COVID-19 human subjects.
Japan’s Food with Functional Claims (FFC) system has recorded its highest number of notifications at 691 products in the first half of the current fiscal year from April 2021 to September 2021, compared to 496 products in the corresponding period last...
See our top 10 most read supplier stories in APAC’s health and nutrition industry this year, featuring winners of the NutraIngredients-Asia Awards 2021, using cell-based milk technology to produce functional foods, and emerging delivery formats for probiotics.
